US Medicare Agency Proposes Expanding Coverage Of Next-Generation Sequencing For Advanced Cancers
Executive Summary
There is sufficient evidence to expand coverage of next-generation sequencing (NGS) as a diagnostic test for ovarian, breast or other advanced cancers if certain criteria are met, the Centers for Medicare and Medicaid Services wrote in a 30 October proposed decision memo.